Equity must be the priority for national pharmacare

Canadians have the chance to consider whether to view access to medicines as a pillar of healthcare, or simply an add-on service.

We remain hopeful that pharmacare legislation, introduced on Feb. 29 by Health Minister Mark Holland, will rekindle Canadian values of affording people access to healthcare based on need, not ability to pay, writes Cathy Ammendolea.The Hill Times photograph by Andrew Meade

Opinion

BY CATHY AMMENDOLEA

April 8, 2024

You might not believe it, but debate about pharmacare predates the implementation of our globally recognized public healthcare system and the 1984 Canada Health Act.

To keep reading, subscribe and become a political insider.

Only $7.76 a week for an annual subscription.

Enjoy unlimited website access and the digital newspaper.

Cancel anytime.

Already a Subscriber?

Get Weekend Point of View Newsletter

A round up of the past weekâ€™s opinion writers and columnists on Saturdays and Sundays.

By entering your email address you consent to receive email from The Hill Times containing news, analysis, updates and offers. You may unsubscribe at any time. See our privacy policy